Home NDC 69036-110 LORTUSS LQ
Product NDC 69036-110
11-digit product format 690360110
Labeler code 69036
Product ID 69036-110_67df3c55-a2b0-4185-8a0d-18754cdae920
Type HUMAN OTC DRUG
Nonproprietary name Doxylamine Succinate, Pseudoephedrine Hydrochloride
Dosage form LIQUID
Route ORAL
Labeler Sallus Laboratories, LLC
Application part341
Marketing category OTC MONOGRAPH FINAL
Marketing start 2014-08-01
Marketing end 0000-00-00
Substance DOXYLAMINE SUCCINATE; PSEUDOEPHEDRINE HYDROCHLORIDE
Active strength 6 mg/5mL; mg/5mL
NDC exclude flag E
Listing certified through 2017-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 26 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 69036-110-16 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 69036-110-16 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 69036-110-16 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 69036-110-16 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 69036-110-16 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 69036-110-16 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 69036-110-16 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 69036-110-16 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 69036-110-16 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 69036-110-16 D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 69036-110-16 D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 69036-110-16 D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2019-12-08 06:16 UTC · source 2019-12-05 excluded product product I Inactivated by FDA 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 69036-110-16 I Inactivated by FDA 110d247fa046…a55b01930146…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
FDA-Initiated Inactive NDC Indexing# DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded DOXYLAMINE SUCCINATE ACTIVE INGREDIENT V9BI9B5YI2 LORTUSS LQ (DOXYLAMINE SUCCINATE, PSEUDOEPHEDRINE HYDROCHLORIDE) LIQUID [SALLUS LABORATORIES, LLC] 1 PSEUDOEPHEDRINE HYDROCHLORIDE ACTIVE INGREDIENT 6V9V2RYJ8N LORTUSS LQ (DOXYLAMINE SUCCINATE, PSEUDOEPHEDRINE HYDROCHLORIDE) LIQUID [SALLUS LABORATORIES, LLC] 1 DOXYLAMINE ACTIVE MOIETY 95QB77JKPL LORTUSS LQ (DOXYLAMINE SUCCINATE, PSEUDOEPHEDRINE HYDROCHLORIDE) LIQUID [SALLUS LABORATORIES, LLC] 1 PSEUDOEPHEDRINE ACTIVE MOIETY 7CUC9DDI9F LORTUSS LQ (DOXYLAMINE SUCCINATE, PSEUDOEPHEDRINE HYDROCHLORIDE) LIQUID [SALLUS LABORATORIES, LLC] 1 AMMONIUM GLYCYRRHIZATE INACTIVE INGREDIENT 3VRD35U26C LORTUSS LQ (DOXYLAMINE SUCCINATE, PSEUDOEPHEDRINE HYDROCHLORIDE) LIQUID [SALLUS LABORATORIES, LLC] 1 CITRIC ACID MONOHYDRATE INACTIVE INGREDIENT 2968PHW8QP LORTUSS LQ (DOXYLAMINE SUCCINATE, PSEUDOEPHEDRINE HYDROCHLORIDE) LIQUID [SALLUS LABORATORIES, LLC] 1 GLYCERIN INACTIVE INGREDIENT PDC6A3C0OX LORTUSS LQ (DOXYLAMINE SUCCINATE, PSEUDOEPHEDRINE HYDROCHLORIDE) LIQUID [SALLUS LABORATORIES, LLC] 1 METHYLPARABEN INACTIVE INGREDIENT A2I8C7HI9T LORTUSS LQ (DOXYLAMINE SUCCINATE, PSEUDOEPHEDRINE HYDROCHLORIDE) LIQUID [SALLUS LABORATORIES, LLC] 1 POTASSIUM CITRATE INACTIVE INGREDIENT EE90ONI6FF LORTUSS LQ (DOXYLAMINE SUCCINATE, PSEUDOEPHEDRINE HYDROCHLORIDE) LIQUID [SALLUS LABORATORIES, LLC] 1 POTASSIUM SORBATE INACTIVE INGREDIENT 1VPU26JZZ4 LORTUSS LQ (DOXYLAMINE SUCCINATE, PSEUDOEPHEDRINE HYDROCHLORIDE) LIQUID [SALLUS LABORATORIES, LLC] 1 PROPYLENE GLYCOL INACTIVE INGREDIENT 6DC9Q167V3 LORTUSS LQ (DOXYLAMINE SUCCINATE, PSEUDOEPHEDRINE HYDROCHLORIDE) LIQUID [SALLUS LABORATORIES, LLC] 1 SUCRALOSE INACTIVE INGREDIENT 96K6UQ3ZD4 LORTUSS LQ (DOXYLAMINE SUCCINATE, PSEUDOEPHEDRINE HYDROCHLORIDE) LIQUID [SALLUS LABORATORIES, LLC] 1 WATER INACTIVE INGREDIENT 059QF0KO0R LORTUSS LQ (DOXYLAMINE SUCCINATE, PSEUDOEPHEDRINE HYDROCHLORIDE) LIQUID [SALLUS LABORATORIES, LLC] 1